Top 10 Companies in the Nanozyme Market (2026): Market Leaders Driving Global Innovation

In Business Insights
August 20, 2026


MARKET INTELLIGENCE OVERVIEW

Nanozyme Market Insights

Global nanozyme market is expanding as researchers leverage the catalytic versatility of nanomaterials to replace fragile natural enzymes, unlocking new possibilities in diagnostics, environmental remediation and industrial catalysis.

📊
Current Market Size
17.5

USD Mn

2025 Value

📈
CAGR
3.2%

2026–2034

🎯
Forecast Market Size
23.2

USD Mn

By 2034

Strategic Market Outlook
Long-Term Industry Perspective
Nanozymes are set to broaden their footprint as manufacturers prioritize stability and cost‑efficiency, especially in markets where cold‑chain logistics pose constraints.

🌐
Leading Region
North America

🌍
Emerging Region
Asia‑Pacific

Nanozymes are nanomaterials that replicate enzyme‑like activity, operating under physiological conditions with kinetics similar to natural catalysts. Their robustness and cost advantage make them attractive for medicine, agriculture, and chemical manufacturing, enabling progress in diagnostics, biosensing, and environmental remediation.

Global nanozyme market size was valued at USD 17.5 million in 2025. The market is projected to grow from USD 18.1 million in 2026 to USD 23.2 million by 2034, exhibiting a CAGR of 3.2% during the forecast period.



Nanozyme Market – View in Detailed Research Report

Top 10 Companies in the Nanozyme Market (2026)

🔟 10. GenScript Biotechnology

Headquarters: United States
Key Offering: Iron‑based and cerium‑oxide nanozymes integrated into point‑of‑care diagnostic kits.

GenScript’s advanced gene‑synthesis infrastructure supports scalable production of high‑purity nanozymes, positioning the firm to supply diagnostic platforms that operate reliably at ambient temperatures.

Sustainability & Growth Initiatives:

  • Investment in continuous‑flow reactors to reduce batch variability.
  • Partnerships with major healthcare providers to accelerate market adoption.
  • Commitment to circular manufacturing through waste‑free synthesis protocols.

đŸ§© 9. Bloomage Bio

Headquarters: China
Key Offering: Copper‑oxide nanozymes produced at large scale with GMP‑grade surface functionalisation.

Bloomage’s polymer‑synthesis lines deliver consistent nanozyme batches that meet stringent pharmaceutical standards, enabling rapid entry into drug‑delivery applications.

Sustainability & Growth Initiatives:

  • Integration of renewable energy sources in production facilities.
  • Collaboration with academic partners to refine surface chemistry for targeted therapeutics.
  • Scaling of modular reactors to reduce capital outlay per unit.

đŸ§Ș 8. ASA Spezialenzyme GmbH

Headquarters: Germany
Key Offering: Metal‑organic framework (MOF) nanozymes offering high selectivity for industrial catalysis.

ASA’s focus on MOF chemistry delivers catalysts that retain activity under harsh process conditions, supporting chemical manufacturers seeking durable solutions.

Sustainability & Growth Initiatives:

  • Development of recyclable MOF frameworks to lower environmental footprint.
  • Strategic alliances with downstream process engineers to tailor catalyst performance.
  • Investments in AI‑driven design of MOF structures for specific reactions.

🔬 7. NanJing NANOEAST BioTech Co., Ltd

Headquarters: China
Key Offering: Peroxidase‑mimicking nanozymes for food‑safety testing kits.

Operating a dedicated nanomaterial foundry, NanJing produces high‑volume nanozyme batches that enable rapid, on‑site pathogen detection in food supply chains.

Sustainability & Growth Initiatives:

  • Implementation of closed‑loop water systems in production lines.
  • Partnerships with regulatory bodies to streamline approval pathways.
  • Continuous improvement of catalyst loading to boost sensitivity.

đŸ©ș 6. Nanozyme, Inc.

Headquarters: United States
Key Offering: Glucose‑oxidase mimetics for continuous glucose monitoring devices.

Nanozyme, Inc. collaborates with wearable‑device manufacturers to embed its catalysts directly onto flexible electrodes, providing real‑time glucose readings without the need for invasive sampling.

Sustainability & Growth Initiatives:

  • Development of biodegradable electrode substrates.
  • Engagement with health insurers to support adoption in chronic disease management.
  • Expansion of sensor platforms to cover a broader spectrum of biomarkers.

⚙ 5. Mitsubishi Chemical Holdings

Headquarters: Japan
Key Offering: Manganese‑doped carbon nanozymes for industrial wastewater treatment.

Targeting processes where traditional enzymes fail due to extreme pH, Mitsubishi’s nanozymes accelerate pollutant degradation while operating under a wide temperature range.

Sustainability & Growth Initiatives:

  • Deployment of modular reactors for scalable treatment solutions.
  • Integration of real‑time monitoring systems to optimise catalyst performance.
  • Collaborations with municipalities to reduce sludge generation.

đŸŒŸ 4. Zhejiang University Nanozyme Center

Headquarters: China
Key Offering: Graphene‑based nanozymes for precision agriculture, degrading pesticide residues in situ.

By converting pesticide residues into harmless by‑products, the centre’s nanozymes enable farmers to reduce chemical usage while maintaining crop protection.

Sustainability & Growth Initiatives:

  • Partnerships with agritech firms to integrate nanozymes into seed coatings.
  • Field trials across multiple continents to validate performance under diverse climates.
  • Investment in scalable synthesis routes to lower cost per kilogram.

⚖ 3. BioNTech

Headquarters: Germany
Key Offering: Nanozyme‑enhanced vaccine adjuvants that improve immune response stability.

Leveraging its expertise in mRNA platforms, BioNTech integrates nanozymes to stabilize vaccine formulations, reducing reliance on cold‑chain logistics.

Sustainability & Growth Initiatives:

  • Development of nanozyme‑based stabilisers that lower vaccine waste.
  • Collaborations with global health agencies to expand distribution in low‑resource settings.
  • Research into multi‑antigen nanozyme carriers for broader protection.

🧬 2. Thermo Fisher Scientific

Headquarters: United States
Key Offering: Nanozyme‑assisted biosensing platforms for high‑throughput screening.

Thermo Fisher’s nanozyme technology enhances assay sensitivity, enabling rapid screening of drug candidates and environmental samples.

Sustainability & Growth Initiatives:

  • Investment in automated synthesis lines to boost throughput.
  • Partnerships with academic labs to accelerate discovery cycles.
  • Implementation of low‑energy consumption processes to reduce carbon footprint.

💉 1. Roche

Headquarters: Switzerland
Key Offering: Nanozyme‑based diagnostic assays for oncology biomarkers.

Roche’s integration of nanozymes into its diagnostic panels delivers faster turnaround times and higher sensitivity, supporting early cancer detection.

Sustainability & Growth Initiatives:

  • Adoption of single‑use, biodegradable assay cartridges.
  • Collaboration with healthcare providers to streamline sample collection.
  • Research into multi‑analyte nanozyme panels for comprehensive diagnostics.



Nanozyme Market – View in Detailed Research Report



Nanozyme Market – View in Detailed Research Report

🌍 Outlook: The Future of Nanozyme Market Is Expanding

Industry momentum is being driven by a shift toward robust, low‑cost catalysts that eliminate the need for cold‑chain logistics, enabling broader deployment across diagnostics, environmental remediation and industrial catalysis. The convergence of advanced manufacturing, digital process control and global supply‑chain integration is positioning nanozymes as a core component of next‑generation production lines.

  • Digital twins of production lines reduce time‑to‑market for new catalyst batches.
  • Cross‑border trade agreements lower regulatory friction for nanozyme exports.
  • Strategic partnerships with OEMs accelerate integration into existing equipment.
  • Rising demand for sustainable manufacturing fuels investment in nanozyme R&D.

📈 Future Trends

Emerging opportunities are set to reshape the nanozyme landscape across multiple sectors:

  • Personalised medicine platforms that synthesize patient‑specific therapeutics on demand.
  • Agri‑tech solutions that release nutrients in response to soil conditions, reducing fertilizer waste.
  • Integration of nanozyme sensors into wearable devices, creating subscription‑based data services.
  • Industrial catalysis that leverages 3‑D structural mimics for higher selectivity and recyclability.
  • Green chemistry initiatives that replace hazardous reagents with recyclable nano‑enzymes.